Overexpression of CD6 and PD-1 Identifies Dysfunctional CD8


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2019
Historique:
received: 29 08 2019
accepted: 06 12 2019
entrez: 31 1 2020
pubmed: 31 1 2020
medline: 18 11 2020
Statut: epublish

Résumé

Effective CD8

Identifiants

pubmed: 31998302
doi: 10.3389/fimmu.2019.03005
pmc: PMC6961594
doi:

Substances chimiques

Antigens, CD 0
Antigens, Differentiation, T-Lymphocyte 0
Biomarkers 0
CD6 antigen 0
Cytokines 0
PDCD1 protein, human 0
Programmed Cell Death 1 Receptor 0

Types de publication

Journal Article Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

3005

Informations de copyright

Copyright © 2020 Enyindah-Asonye, Nwankwo, Rahman, Hunegnaw, Hogge, Helmold Hait, Ko, Hoang and Robert-Guroff.

Références

J Exp Med. 2016 Jul 25;213(8):1387-97
pubmed: 27377588
Mol Cell Biol. 2017 May 16;37(11):
pubmed: 28289074
Curr Drug Targets. 2016;17(6):630-9
pubmed: 26028048
Annu Rev Immunol. 2003;21:29-70
pubmed: 12414723
Expert Opin Biol Ther. 2017 Mar;17(3):395-402
pubmed: 28064543
Mol Immunol. 2008 Feb;45(4):963-70
pubmed: 17868872
J Biol Chem. 2017 Jan 13;292(2):661-671
pubmed: 27909060
J Virol. 2007 Dec;81(24):13456-68
pubmed: 17913797
PLoS Pathog. 2016 Jan 07;12(1):e1005349
pubmed: 26741490
J Virol Methods. 2000 Apr;86(1):61-70
pubmed: 10713377
Virology. 2015 Oct;484:323-33
pubmed: 26151223
BioDrugs. 2013 Jun;27(3):191-202
pubmed: 23568178
Front Immunol. 2019 Mar 19;10:511
pubmed: 30941141
Nature. 2006 Feb 9;439(7077):682-7
pubmed: 16382236
J Immunol. 2017 Nov 1;199(9):3202-3211
pubmed: 28947538
Cell Rep. 2018 Apr 3;23(1):39-49
pubmed: 29617671
Vet Res. 2018 Jun 19;49(1):50
pubmed: 29914540
Annu Rev Med. 2018 Jan 29;69:301-318
pubmed: 29414259
PLoS One. 2017 Jul 3;12(7):e0180088
pubmed: 28672038
Curr HIV/AIDS Rep. 2011 Mar;8(1):4-11
pubmed: 21188556
Immunol Rev. 2009 May;229(1):114-25
pubmed: 19426218
Annu Rev Immunol. 2008;26:677-704
pubmed: 18173375
Immunity. 2016 Sep 20;45(3):656-668
pubmed: 27653601
Clin Exp Immunol. 2010 Oct;162(1):116-30
pubmed: 20726988
Proc Natl Acad Sci U S A. 2018 May 1;115(18):4749-4754
pubmed: 29654146
J Immunol. 2011 Oct 1;187(7):3730-7
pubmed: 21873525
EMBO J. 1992 Nov;11(11):3887-95
pubmed: 1396582
J Immunol. 2013 Dec 15;191(12):6060-70
pubmed: 24227774
Eur J Immunol. 2012 Jan;42(1):195-205
pubmed: 21956609
Proc Natl Acad Sci U S A. 2017 Mar 7;114(10):2687-2692
pubmed: 28209777
Science. 2017 Mar 31;355(6332):1428-1433
pubmed: 28280247
Cancer Res. 2015 Feb 1;75(3):508-518
pubmed: 25480946
Curr Drug Targets. 2016;17(6):666-77
pubmed: 26844560
J Virol. 2005 Apr;79(8):4877-85
pubmed: 15795273
Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14733-8
pubmed: 20679213
J Clin Invest. 2012 May;122(5):1712-6
pubmed: 22523065
Immunology. 2010 Apr;129(4):474-81
pubmed: 20201977
J Virol. 2003 Apr;77(8):4911-27
pubmed: 12663797
Blood. 2007 Aug 1;110(3):928-36
pubmed: 17440051
Philos Trans R Soc Lond B Biol Sci. 2000 Mar 29;355(1395):363-7
pubmed: 10794056
Front Immunol. 2018 Dec 18;9:2994
pubmed: 30619347
J Virol. 2008 Mar;82(6):3154-60
pubmed: 18160439
J Immunol. 2009 May 15;182(10):5891-7
pubmed: 19414738
Am J Vet Res. 1979 Feb;40(2):271-3
pubmed: 111588
Front Immunol. 2014 Apr 16;5:171
pubmed: 24795718
J Immunol. 2018 Apr 15;200(8):2714-2726
pubmed: 29507105
For Immunopathol Dis Therap. 2015;6(1-2):7-17
pubmed: 28286692
J Exp Med. 2012 Jun 4;209(6):1201-17
pubmed: 22641383
Curr Opin Immunol. 1991 Aug;3(4):471-5
pubmed: 1684507
Clin Cancer Res. 2016 Apr 15;22(8):1856-64
pubmed: 27084739

Auteurs

Gospel Enyindah-Asonye (G)

Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.

Anthony Nwankwo (A)

Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.

Mohammad Arif Rahman (MA)

Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.

Ruth Hunegnaw (R)

Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.

Christopher Hogge (C)

Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.

Sabrina Helmold Hait (S)

Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.

Eun-Ju Ko (EJ)

Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.

Tanya Hoang (T)

Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.

Marjorie Robert-Guroff (M)

Vaccine Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, United States.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH